Vanguard Group’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.24M Buy
178,846
+148,370
+487% +$2.69M ﹤0.01% 3361
2025
Q1
$624K Hold
30,476
﹤0.01% 3832
2024
Q4
$783K Buy
30,476
+17,031
+127% +$438K ﹤0.01% 3829
2024
Q3
$223K Hold
13,445
﹤0.01% 4117
2024
Q2
$258K Buy
+13,445
New +$258K ﹤0.01% 4131